Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Morgan Stanley analyst Betsy Graseck downgraded the rating for Bank of America Corporation BAC from Overweight to Equal-Weight but raised the price target from $48 to $55. Bank of America shares closed at $46.75 on Friday. See how other analysts view this stock.
- Leerink Partners analyst Puneet Souda downgraded Myriad Genetics, Inc. MYGN from Outperform to Market Perform and slashed the price target from $30 to $21. Myriad Genetics shares closed at $15.13 on Friday. See how other analysts view this stock.
- Jefferies analyst Michael Yee downgraded the rating for Biogen Inc. BIIB from Buy to Hold and lowered the price target from $250 to $180. Biogen shares closed at $157.78 on Friday. See how other analysts view this stock.
- B of A Securities analyst Vivek Arya downgraded Advanced Micro Devices, Inc. AMD from Buy to Neutral and lowered the price target from $180 to $155. AMD shares closed at $138.59 on Friday. See how other analysts view this stock.
- JP Morgan analyst Sandeep Deshpande downgraded the rating for STMicroelectronics N.V. STM from Overweight to Neutral. STMicroelectronics shares closed at $26.43 on Friday. See how other analysts view this stock.
Considering buying AMD stock? Here’s what analysts think:
Read This Next:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
